FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/05/033660 [Registered on: 17/05/2021] Trial Registered Prospectively
Last Modified On: 13/05/2021
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Unani 
Study Design  Single Arm Study 
Public Title of Study   Treatment of Gout (Pain in joints) with Unani medicines Majoon-e-Yahya Bin Khalid and Roghan-e-Naf-e-Warm-e-Niqras 
Scientific Title of Study   Clinical study on validation of Unani Pharmacopoeial formulation Majoon e Yahya Bin Khalid and Roghan e Naf e Niqras in Niqras (Gout) 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
N/G/MY-RN/CLNVAL/CCRUM/19-20, Version 2  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Prof Asim Ali Khan  
Designation  Director General 
Affiliation  Central Council for Research in Unani Medicine (CCRUM)  
Address  Room no. 502, Central Council for Research in Unani Medicine (CCRUM) Jawahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri

South West
DELHI
110058
India 
Phone  01128525715   
Fax    
Email  unanimedicine@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Naheed Parveen  
Designation  Assistant Director 
Affiliation  Central Council for Research in Unani Medicine (CCRUM)  
Address  Room no. 507, Central Council for Research in Unani Medicine (CCRUM) Jawahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri

South West
DELHI
110058
India 
Phone  9213511298   
Fax    
Email  ccrum507@rediffmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Pradeep Kumar 
Designation  Research Officer (Pathology) S-IV 
Affiliation  Central Council for Research in Unani Medicine (CCRUM)  
Address  Room no. 516, Central Council for Research in Unani Medicine (CCRUM) Jawahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri

South West
DELHI
110058
India 
Phone  8800263300  
Fax    
Email  drpradeepkumar2001@yahoo.com  
 
Source of Monetary or Material Support  
Infrastructural support : 1 Regional Research Institute of Unani Medicine (RRIUM), Aligarh Monetary Support : Central Council for Research in Unani Medicine (CCRUM), New Delhi  
 
Primary Sponsor  
Name  Central Council for Research in Unani Medicine CCRUM New Delhi 
Address  Jawahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri, New Delhi-110058. 
Type of Sponsor  Research institution 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Rashid ul Islam  Regional Research Institute of Unani Medicine, Aligarh  Research OPD Room Niqras (Gout) Post Box No. 70, Shahjahan Manzil, Near AMU Riding Club, Qila Road
Aligarh
UTTAR PRADESH 
9897975161

waytorashid@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Regional Research Institute of Unani Medicine, Aligarh  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M100||Idiopathic gout,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Majoon-e-Yahya Bin Khalid and Roghan-e-Naf-e-Warm-e-Niqras  5gm orally twice daily to be taken with water and massage with 2ml oil locally twice daily for twelve weeks respectively 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1. Subjects of either sex between the age groups of 18 years to 65 years.
2. Subjects fulfilling the 2015ACR/EULAR-criteria for diagnosis of gout(≥8)
 
 
ExclusionCriteria 
Details  1. Acute Gouty arthritis
2. Subjects having any systemic illness requiring long term treatment
3. Pregnant and lactating women
4. Intolerant to therapy
5. Subjects who received any local injection in the previous 3 months 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Improvement in sign and symptoms of Niqras (Gout)  every 2 weeks for twelve weeks 
 
Secondary Outcome  
Outcome  TimePoints 
Haematological and biochemical assessment for safety assessment  Investigations will be done at baseline and end of treatment 
 
Target Sample Size   Total Sample Size="110"
Sample Size from India="110" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   17/05/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Not yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is designed as a single arm trial in patients with Niqras (Gout). After screening, patients will be enrolled if they satisfy inclusion and exclusion criteria. The patients will be treated with Unani pharmacopoeial formulations Majoon-e-Yahya Bin Khalid and Roghan-e- Naf-e- Warm-e-Niqras. 5gm of Majoon-e-Yahya Bin Khalid shall be given orally twice a day and 2ml of Roghan-e- Naf-e- Warm-e-Niqras shall be applied locally twice a day. Both the formulations will be given for 12 weeks.  The patients will be assessed clinically at every 2 weeks of treatment.  This includes subjective assessment of general well being and physical examination . The total duration of treatment will be 12weeks. Laboratory parameters for safety assessment will be conducted at baseline and on completion of the protocol therapy.

(A) Composition of Majoon-e-Yahya Bin Khalid48

S. No.

Ingredients

Botanical/Scientific Name

Quantity

1.

Asaroon

AsarumeuropeaumLinn.

75 g.

2.

Zanjabeel

Zingiber officinaleRosc.

75g.

3.

Zeera Siyah

CarumcarviLinn.

75g.

4.

FilfilDaraz

Piper longumLinn.

75g.

5.

Suranjan Shireen

Colchicum autumnale

75g.

6.

Sana

Cassia Angustifolia Vahl.

75g.

7.

QandSafaid

Refined sugar

250g.

(B) Composition of Roghan-e-Warm-e-Naf-e-Niqras47[AR1] 

S. No.

Ingredients

Botanical/Scientific Name

Quantity

1.

Babuna

Matricaria chamomilla Linn.

100g.

2.

Anab-us-Salab

Solanum nigrum Linn.

100g.

3.

Parsiaoshan

Adiantum capillus-veneris Linn.

100g.

4.

Ikleel-ul-Malik

TrigonellaUncataBoiss.

100g.

5.

Barg-e-Hina

Lawsoniainermis Linn.

100g.

6.

Suranjan

Colchicum luteum Baker.

100g.

7.

Buzidan

Orchis latifoliaLinn.

100g.

8.

Mughas (MaidaLakri)

LitseachinensisLinn.

100g.

9.

Gul-e-Khatami

Althaea officinalis Linn.

100g.

10.

Gul-e-Babuna

MatricariachamonillaLinn.

100g.

11.

Asl-us-Soos                      

Glycyrrhiza glabra Linn.

100g.

12.

Irsa

Iris ensataThunb.

80g.

13.

Aab

Water

5 Lit

14.

Roghan-e-Kunjad

Sesamum indicum Linn.

Q.S

15.

Roghan-e-Zeet

Oil of Olea europaea L.

Q.S

16.

Roghan-e-Tukhm-e-Khashkhaash

Oil ofPapaver somniferum Linn.

Q.S

17.

Roghan-e-Tukhm-e-Kharpaza

Oil ofCucumismelo Linn.

Q.S


 [AR1]

 
Close